Company intelligence / Profile preview

Aries Pharmaceuticals

San Diego, California, United States

Ownership: Private
Employees: ~65
Development stage: Other

Overview

Aries Pharmaceuticals distributes Cosmo Pharmaceuticals’ gastrointestinal and endoscopy products in the US, including commercial products such as the submucosal injection agent Eleview and late-stage/marketed small‑molecule products like rifamycin SV MMX and remimazolam; the group also includes a Pakistan-based manufacturer active in generic and branded drugs.[1][9]

Therapeutic areas: OncologyOtherGastroenterology
Modalities: Small moleculeDevice
Industry: Biotech

Partnerships

Cosmo Pharmaceuticals (product development and supply; Aries handles US distribution)[5][7][9]

Beyond the preview

Go deeper on Aries Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aries Pharmaceuticals.

Explore the full profile